Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Bortezomib Regimen on Multiple Myeloma Patients Infected With Covid-19 Publisher



Rezaeian Z1 ; Abedini F1 ; Arabzadeh S1 ; Farzan M2 ; Sharifi M1, 3 ; Manteghinejad A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Prevention Research Center, Omid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Middle East Journal of Cancer Published:2023


Abstract

Background: Patients with multiple myeloma (MM) have compromised immune systems due to the nature of the malignancy and anticancer treatments. This study aims to report the effects of Bortezomib-containing chemotherapy regimens on the severity and mortality of MM patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). Method: This retrospective cohort study enrolled MM patients presenting with coronavirus disease 2019 (COVID-19) infection referred to Omid Hospital. Patients were divided into two groups based on whether they received any chemotherapy regimens containing Bortezomib within the last 90 days of admission or not. Clinical and laboratory characteristics, severity, and outcomes of both groups were reported and compared. Results: Among 48 patients with MM diagnosed with COVID-19 (63% male; median age 66), 33 received chemotherapy. The most common symptoms were fever, cough, and dyspnea, and there was no significant difference between the groups. Only D-dimer had a significant difference in laboratory tests (P = 0.03) and was higher in the chemotherapy group. There was no significant relationship between chemotherapy and severity (risk ratio (RR) = 1.17; 95% confidence interval (CI): 0.37 to 3.71; P = 0.79) or chemotherapy and mortality (RR= 1.00; 95% CI: 0.39 to 2.61; P = 0.99), even after adjusting for baseline C-reactive protein and white blood cell counts. Conclusion: Our study showed that receiving Bortezomib-containing chemotherapy regimens did not worsen the symptoms and prognosis of MM patients infected with COVID-19. However, further studies with larger sample sizes and longer follow-up times are needed to provide better evidence on this subject. © 2023, Shiraz University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
2. Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection, Acta Medica Indonesiana (2021)
3. Subcutaneous Tocilizumab in Adults With Severe and Critical Covid-19: A Prospective Open-Label Uncontrolled Multicenter Trial, International Immunopharmacology (2020)
4. Acute Mesenteric Ischemia in a Patient With Covid-19: A Case Report, Archives of Iranian Medicine (2020)
5. Vaccine-Associated Complications: A Comparative Multicenter Evaluation Among Dental Practitioners and Dental Students—Which Candidate Vaccine Is More Safe in Sars Cov Ii, Gam-Covid-Vac (Sputnik V), Chadox1 Ncov-19 (Astrazeneca), Bbv152 (Covaxin), or Bbibp-Corv(Sinopharm)?, Maxillofacial Plastic and Reconstructive Surgery (2022)
6. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
7. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic Covid-19 in 2020 and 2021, JAMA (2022)
8. Covid-19 Breakthrough Infections Among Patients With Cancer Receiving Sinopharm Bibp Vaccine, International Journal of Cancer Management (2022)
Experts (# of related papers)
View all Related Experts
Ramin Sami (7)
Shaghayegh Haghjooy Javanmard (6)
Other Related Docs
9. Infliximab and Intravenous Gammaglobulin in Hospitalized Severe Covid-19 Patients in Intensive Care Unit, Archives of Iranian Medicine (2021)
10. Risk Factors for the Mortality in Hospitalized Patients With Covid-19: A Brief Report, Iranian Journal of Medical Sciences (2021)
11. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
12. Cancer Patients’ Challenges During Covid-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making, Archives of Clinical Infectious Diseases (2021)
13. Covid19 Prevention & Care; a Cancer Specific Guideline, Archives of Iranian Medicine (2020)
14. A Study on the Effect of Aspirin on Clinical Symptoms, Laboratory Indices, and Outcomes in Patients With Covid-19, Journal of Nephropharmacology (2023)
15. Electrolyte Abnormalities in Hospitalized Covid-19 Patients at Tertiary Referral Centers in Tehran: Hypermagnesemia As a Marker of Fatality: A Retrospective Cross-Sectional Study, Health Science Reports (2023)
16. An Experimental in Silico Study on Covid-19: Response of Neutrophil-Related Genes to Antibiotics, Health Science Reports (2022)
17. Association of Prior Covid‑19 Infection With Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran, International Journal of Preventive Medicine (2024)
18. Case Report: Barotrauma in Covid-19 Case Series, American Journal of Tropical Medicine and Hygiene (2021)
19. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
20. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
21. The Severity of Symptoms and Outcomes of Patients Admitted With Rheumatic Diseases and Covid-19; a Prospective Cohort Study in Iran, Immunopathologia Persa (2021)
22. Fatal Invasive Pulmonary Aspergillosis in Covid-19 Patient With Acute Myeloid Leukemia in Iran, Mycopathologia (2020)
23. Co-Infection Between the Severe Acute Respiratory Syndrome Coronavirus 2 and the Influenza Type B in Isfahan, Iran, Journal of Research in Medical Sciences (2021)
24. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
25. Covid-19, an Early Investigation From Exposure to Treatment Outcomes in Tehran, Iran, Journal of Research in Medical Sciences (2021)
26. The Clinical Manifestation and Outcome of Covid-19 in Patients With a History of Ischemic Heart Disease; a Retrospective Case-Control Study, BMC Cardiovascular Disorders (2023)
27. A Complementary Critical Appraisal on Systematic Reviews Regarding the Most Efficient Therapeutic Strategies for the Current Covid-19 (Sars-Cov-2) Pandemic, Journal of Medical Virology (2021)
28. The Role of Cytokine Profile and Lymphocyte Subsets in the Severity of Coronavirus Disease 2019 (Covid-19): A Systematic Review and Meta-Analysis, Life Sciences (2020)
29. A Mini-Review on Cardiovascular and Hematological Complications of Covid-19, Coronaviruses (2021)
30. Unexpected Positive Effects of Rituximab and Corticosteroids on Covid-19 in a Patient Suffering From Granulomatosis With Polyangiitis, Advanced Biomedical Research (2021)
31. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)
32. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
33. Clinical Characteristics of Covid-19-Infected Cancer Patients, Isfahan, Iran, Journal of Research in Medical Sciences (2022)
34. Effectiveness of Bbibp-Corv Vaccine in Preventing Sars-Cov2 Infection and Severe Outcomes in People Living With Multiple Sclerosis: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
35. Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study, Journal of Nephropharmacology (2023)
36. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)
37. Nervous System Involvement in Covid-19: A Review of the Current Knowledge, Molecular Neurobiology (2021)
38. Comparison of Omicron and Delta Variants of Sars-Cov-2: A Systematic Review of Current Evidence, Infectious Disorders - Drug Targets (2024)
39. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
40. The Prevalence of Covid-19 Infection in Patients With Multiple Sclerosis (Ms): A Systematic Review and Meta-Analysis, Neurological Sciences (2021)
41. Thrombocytopenia and Coronavirus: A Prognosis and Progression of the Coronavirus Disease, Iranian Journal of Pediatric Hematology and Oncology (2022)
42. The Effect of Vitamin E and Vitamin C in Patients With Covid-19 Pneumonia; a Randomized Controlled Clinical Trial, Immunopathologia Persa (2022)
43. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
44. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
45. Hemoperfusion in Patients With Severe Covid-19 Respiratory Failure, Lifesaving or Not?, Journal of Research in Medical Sciences (2021)
46. Diagnostic Value of Antibody Testing in Comparison With Lung Scan and Pcr in Patients Suspected of Having Covid-19, Iranian Journal of Microbiology (2024)
47. Bortezomib in Combination With Low-Dose Oral Melphalan, Dexamethasone and Thalidomide for Relapsed Elderly Patients With Multiple Myeloma, Journal of Research in Medical Sciences (2012)